Adjuvant IL-7 antagonizes multiple cellular and molecular inhibitory networks to enhance immunotherapies
Marc Pellegrini(University of Melbourne), Tak W. Mak(Ontario Institute for Cancer Research), Brigitte Assouline, Matthew A. Gronski(Carter Center), Linh T. Nguyen(University Health Network), Dilan Dissanayake(Hospital for Sick Children), Amy E. Lin(University of California, San Francisco), Pamela S. Ohashi(Ontario Institute for Cancer Research), Arda Shahinian(Ontario Institute for Cancer Research), Thomas Calzascia(Ontario Institute for Cancer Research), Tim Sparwasser(University Medical Center of the Johannes Gutenberg University Mainz), Katharina Lahl(Lund University), Michel Morre, Alisha R. Elford(Ontario Institute for Cancer Research), Salim Dhanji(University Health Network)
Cited by 226
Related Papers
Cancer classification using the Immunoscore: a worldwide task force
|Journal of Translational Medicine|2012|803
Metabolic pathways in T cell activation and lineage differentiation
|Seminars in Immunology|2016|479
IL-7 Engages Multiple Mechanisms to Overcome Chronic Viral Infection and Limit Organ Pathology
|Cell|2011|304
Clonal Hematopoiesis
|Journal of the American College of Cardiology|2019|237